Smartgroup Corporation Ltd (ASX:SIQ) Reports 10% Revenue Growth in Q1 2025
Smartgroup Corporation Ltd (ASX:SIQ) reports a 10% revenue increase in Q1 2025, driven by strong novated leasing demand and strategic partnerships.
Category: Companies
LTR Pharma Limited (ASX:LTP) Signs Collaborative Agreement for OROFLOW® Development
LTR Pharma (ASX:LTP) collaborates with SDS to develop OROFLOW®, a novel intranasal spray for Oesophageal Motility Disorders.
Geopacific Resources Limited (ASX:GPR) Unlocks New Porphyry Cu-Au Potential on Woodlark Island
Geopacific Resources (ASX:GPR) reveals 14 new porphyry Cu-Au targets at Woodlark Gold Project, boosting exploration prospects.
Credit Corp Group (ASX:CCP) Releases FY25 Market Update
Credit Corp Group (ASX:CCP) outlines its FY25 financial targets and strategic growth initiatives across US and Australian/NZ markets in its latest market update.
Regis Healthcare Limited (ASX:REG) Reports Strong H1 FY25 Financial Performance
Regis Healthcare Limited (ASX:REG) reports a 17.5% revenue increase in H1 FY25, highlighting significant growth and financial stability.
Spectur Limited (ASX:SP3) Appoints New CEO and Reports Strong Revenue Growth
Spectur Limited (ASX:SP3) appoints Anthony Schmidt as CEO and reports over $7M revenue for FY2023, highlighting strong growth and strategic expansion.
Brightstar Resources Limited (ASX:BTR) Announces Gold Drilling Results
Brightstar Resources (ASX:BTR) announces significant gold drilling results, advancing exploration and operational activities.
Swift Networks Group Ltd (ASX:SW1) Closes $3.3 Million Entitlement Offer
Swift Networks Group Ltd (ASX:SW1) closes $3.3M entitlement offer, raising $2.3M to fund product development and reduce debt.
Generation Development Group Limited (ASX:GDG) Forms Strategic Alliance with BlackRock
Generation Development Group Limited (ASX:GDG) partners with BlackRock to develop holistic retirement solutions for Australian retirees.
Algorae Pharmaceuticals (ASX:1AI) Partners with Peter MacCallum Cancer Centre for AI-Driven Drug Screening
Algorae Pharmaceuticals (ASX:1AI) partners with Peter MacCallum Cancer Centre to validate AI-driven drug synergies in oncology.